Bell-shaped agonist activation of 5-HT1A receptor-coupled Gαi3 G-proteins: Receptor density-dependent switch in receptor signaling-Reference-Cited by-同舟云学术

Bell-shaped agonist activation of 5-HT1A receptor-coupled Gαi3 G-proteins: Receptor density-dependent switch in receptor signaling

Published:2019-11 Issue: Volume:63 Page:109383
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Newman-Tancredi A.^ORCID,Cussac D.,Ormière A.-M.,Lestienne F.,Varney M.A.,Martel J.-C.

Funder

Pierre Fabre Laboratories

Publisher

Elsevier BV

Subject

Cell Biology

Reference51 articles.

1. How much do we know about the coupling of G-proteins to serotonin receptors?;Giulietti;Mol Brain,2014

2. 5-HT1A agonists and dyskinesia in Parkinson's disease: a pharmacological perspective;Huot;Neurodegener. Dis. Manag.,2018

3. Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression;Albert;Front. Behav. Neurosci.,2014

4. Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research;Celada;CNS Drugs,2013

5. The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives;Newman-Tancredi;Curr. Opin. Investig. Drugs,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of the 5-HT1A receptor in zebrafish responses to potential threat and in sociality;2024-04-18

2. The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression;CNS Drugs;2023-06-29

3. Evidence for Endogenous Opioid Dependence Related to Latent Sensitization in a Rat Model of Chronic Inflammatory Pain;International Journal of Molecular Sciences;2023-02-01

4. Changes in Targets as an Explanation for Drug Resistance in Epilepsy;Pharmacoresistance in Epilepsy;2023

5. Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders;Pharmacology & Therapeutics;2022-01